BACKGROUND: Movement abnormalities and cognitive deficits may represent external markers of an underlying neural process linked with the early etiology of psychosis. As basal ganglia function plays a governing role in both movement and cognitive processes, an understanding of the relationship between these phenomena stands to inform etiologic conceptualizations of vulnerability and psychotic disorders. METHODS: In this investigation, trained raters coded movement abnormalities in videotapes from structured interviews of adolescents and young adults with a prodromal risk syndrome (n = 90). The participants were administered a neuropsychological battery including measures of verbal comprehension, perceptual organization, immediate/delayed auditory memory, and an estimate of full-scale intelligence quotient. Diagnostic status was followed for a 2-year period utilizing structured clinical interviews, during which time 24 high-risk participants (26.66%) converted to an Axis I psychotic disorder. RESULTS: Elevated dyskinetic movements in the upper-body region were correlated with deficits in domains of verbal comprehension, perceptual organization, and both immediate and delayed auditory memory. Further, discriminant function analyses indicated that baseline movement abnormalities and neurocognitive deficits significantly classified those high-risk participants who would eventually convert to a psychotic disorder (72.3%). CONCLUSIONS: Results support a common cortico-striato-pallido-thalamic circuit irregularity, underlying both movement abnormalities and cognitive deficits in individuals at high risk for psychosis. Models incorporating external markers of progressive basal ganglia dysfunction may enhance detection and preventive intervention for those high-risk individuals most in need of treatment. Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
BACKGROUND:Movement abnormalities and cognitive deficits may represent external markers of an underlying neural process linked with the early etiology of psychosis. As basal ganglia function plays a governing role in both movement and cognitive processes, an understanding of the relationship between these phenomena stands to inform etiologic conceptualizations of vulnerability and psychotic disorders. METHODS: In this investigation, trained raters coded movement abnormalities in videotapes from structured interviews of adolescents and young adults with a prodromal risk syndrome (n = 90). The participants were administered a neuropsychological battery including measures of verbal comprehension, perceptual organization, immediate/delayed auditory memory, and an estimate of full-scale intelligence quotient. Diagnostic status was followed for a 2-year period utilizing structured clinical interviews, during which time 24 high-risk participants (26.66%) converted to an Axis I psychotic disorder. RESULTS:Elevated dyskinetic movements in the upper-body region were correlated with deficits in domains of verbal comprehension, perceptual organization, and both immediate and delayed auditory memory. Further, discriminant function analyses indicated that baseline movement abnormalities and neurocognitive deficits significantly classified those high-risk participants who would eventually convert to a psychotic disorder (72.3%). CONCLUSIONS: Results support a common cortico-striato-pallido-thalamic circuit irregularity, underlying both movement abnormalities and cognitive deficits in individuals at high risk for psychosis. Models incorporating external markers of progressive basal ganglia dysfunction may enhance detection and preventive intervention for those high-risk individuals most in need of treatment. Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Authors: Tandy J Miller; Thomas H McGlashan; Joanna Lifshey Rosen; Lubna Somjee; Philip J Markovich; Kelly Stein; Scott W Woods Journal: Am J Psychiatry Date: 2002-05 Impact factor: 18.112
Authors: R Cosway; M Byrne; R Clafferty; A Hodges; E Grant; J Morris; S S Abukmeil; S M Lawrie; P Miller; D G C Owens; E C Johnstone Journal: Psychol Med Date: 2002-02 Impact factor: 7.723
Authors: Vijay A Mittal; Maria Jalbrzikowski; Melita Daley; Cristina Roman; Carrie E Bearden; Tyrone D Cannon Journal: Schizophr Res Date: 2011-06-01 Impact factor: 4.939
Authors: Sanne de Wit; Tim B Ziermans; M Nieuwenhuis; Patricia F Schothorst; Herman van Engeland; René S Kahn; Sarah Durston; Hugo G Schnack Journal: Hum Brain Mapp Date: 2016-10-04 Impact factor: 5.038
Authors: Xiaoming Du; Fow-Sen Choa; Joshua Chiappelli; Krista M Wisner; George Wittenberg; Bhim Adhikari; Heather Bruce; Laura M Rowland; Peter Kochunov; L Elliot Hong Journal: Biol Psychiatry Date: 2018-06-21 Impact factor: 13.382
Authors: Derek J Dean; Jessica A Bernard; Katherine S F Damme; Randall O'Reilly; Joseph M Orr; Vijay A Mittal Journal: Schizophr Bull Date: 2020-12-01 Impact factor: 9.306
Authors: Jessica A Bernard; Derek J Dean; Jerillyn S Kent; Joseph M Orr; Andrea Pelletier-Baldelli; Jessica R Lunsford-Avery; Tina Gupta; Vijay A Mittal Journal: Hum Brain Mapp Date: 2014-01-24 Impact factor: 5.038